Phase I/II, Multicenter, Single-Arm Clinical Trial of Panitumumab in Combination with Cisplatin, Fluourouracil and Docetaxel (DCF) in Locally Advanced or Metastatic Cancer of the Stomach and Gastro-oesophageal junction
Phase of Trial: Phase I/II
Latest Information Update: 02 May 2016
At a glance
- Drugs Panitumumab (Primary) ; Cisplatin; Docetaxel; Fluorouracil; Pazopanib
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 28 Apr 2016 Status changed from discontinued to completed.
- 07 Oct 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 29 Oct 2012 Planned end date 1 Jul 2014 added as reported by ClinicalTrials.gov.